Recent Articles


Medidata: Streamlining Clinical Trials

Tickers: MDSO

This featured recommendation focuses on a niche market, providing applications that manage all aspects of heavily regulated clinical trials in…


Four “Unique” Funds from Fidelity

In his latest Fidelity Investor, fund expert Jim Lowell looks at a number of buy-rated funds that would qualify as having unique…


GlaxoSmithKline: A Pharma Favorite

Tickers: GSK

Barring discovery of the Fountain of Youth, demand for healthcare is growing around the world as populations age in developed countries and as…


Net-Net: A Formula for Value

Tickers: AVT

J. Royden Ward is an expert on value investing strategies. Here, the editor of Cabot Benjamin Graham Value Investor, explains…


3 Trading Tips for RSI

Tickers: GBP-USD

Walker England of lays out the three uncommon tips for trading with RSI so traders can get more comfortable with the…


iShares Eyes Dividend Growth

Tickers: DGRO

Dividend growth at iShares. In June, iShares unveiled its first ETF focused on dividend growth, which combines several dividend growth criteria…


BDCs: High Yields in Finance

Tickers: TCAP, PSEC

Income expert Briton Ryle highlights a pair of financing firms-known as Business Development Companies-that are both ongoing buys…